| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |